Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Jul 7, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | A | $57.50 | A | $39.05 | 47.26% | 20.91x | 16.52x | 3.72x | 1.90x | 0.87x | $624.18M | 5.69% | $5.79B | 30.34 | $10.57B | 13.60 |
| PEN | PENUMBRA INC | A | $251.06 | C | $37.44 | 570.66% | 228.24x | 67.52x | 7.81x | 8.02x | 2.88x | $150.33M | 1.55% | $1.21B | 31.45 | $9.57B | 134.18 |
| PEGA | PEGASYSTEMS INC | A | $54.03 | C | $9.33 | 478.91% | 47.19x | 43.40x | 5.65x | 15.05x | 6.67x | $361.02M | 3.89% | $611.27M | 3.56 | $9.03B | 27.59 |
| WIX | WIXCOM LTD | A | $164.29 | C | $45.24 | 263.18% | 61.53x | 54.04x | 5.04x | -54.28x | 1.95x | $514.81M | 5.62% | -$168.62M | -3.03 | $9.46B | 59.70 |
| BGC | BGC GROUP INC | A | $10.85 | C | $27.98 | -61.22% | 38.75x | 9.12x | 2.21x | 5.50x | 0.15x | $215.76M | 4.15% | $963.78M | 2.01 | $6.00B | 16.41 |
| ACIW | ACI WORLDWIDE INC | A | $46.21 | B | N/A | N/A | 17.98x | 19.02x | 2.91x | 3.27x | N/A | $299.36M | 6.15% | $1.48B | 14.07 | $5.48B | 10.66 |
| PTCT | PTC THERAPEUTICS INC | A | $49.07 | B | N/A | N/A | 6.49x | 6.35x | 2.16x | -20.94x | N/A | $871.14M | 22.73% | -$185.76M | -2.38 | $2.80B | 3.30 |
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | A | $22.12 | C | $8.69 | 154.65% | 73.73x | 25.50x | 0.38x | 2.28x | 1.13x | $127.50M | 2.87% | $1.69B | 8.40 | $6.52B | 13.90 |
| ENS | ENERSYS | A | $90.22 | A | $72.76 | 24.00% | 9.86x | 9.29x | 0.99x | 1.85x | 1.51x | $141.13M | 3.93% | $1.92B | 48.19 | $4.31B | 7.71 |
| AMRX | AMNEAL PHARMACEUTICALS INC | A | $8.42 | B | N/A | N/A | -210.50x | 13.22x | 0.93x | -20.04x | N/A | $243.04M | 9.28% | -$131.67M | -0.42 | $5.15B | 10.24 |
| CPRX | CATALYST PHARMACEUTICALS INC | A | $21.46 | A | $19.15 | 12.06% | 13.01x | 9.92x | 4.88x | 3.30x | 0.78x | $267.57M | 10.27% | $794.28M | 6.54 | $2.04B | 6.88 |
| ARDT | ARDENT HEALTH PARTNERS INC | A | $13.39 | A | $16.07 | -16.66% | 7.97x | 6.96x | 0.31x | 1.63x | 0.72x | $118.35M | 6.31% | $1.18B | 8.39 | $3.70B | 7.39 |
| CINT | CI&T INC | A | $6.07 | C | $3.20 | 89.89% | 24.28x | 22.07x | 1.78x | N/A | 1.21x | $70.97M | 8.68% | N/A | N/A | N/A | N/A |
| DLX | DELUXE CORP | A | $17.15 | A | $54.95 | -68.79% | 13.61x | 5.89x | 0.36x | 1.23x | 0.13x | $118.06M | 15.39% | $622.46M | 13.91 | $2.28B | 6.01 |
| HRTG | HERITAGE INSURANCE HOLDINGS INC | A | $23.05 | A | $34.72 | -33.62% | 9.07x | 7.10x | 0.85x | 2.17x | 0.40x | $73.53M | 10.39% | $329.00M | 10.72 | $393.92M | 3.19 |
| LYTS | LSI INDUSTRIES INC | A | $17.85 | B | $14.38 | 24.16% | 24.12x | 17.67x | 0.98x | 2.42x | 0.63x | $36.49M | 6.81% | $221.71M | 7.39 | $600.18M | 13.55 |
| QUAD | QUAD/GRAPHICS INC | A | $5.82 | B | N/A | N/A | -16.17x | 6.54x | 0.11x | 3.37x | N/A | $73.00M | 26.13% | $87.40M | 1.82 | $838.46M | 5.85 |
| MAPS | WM TECHNOLOGY INC | A | $0.92 | A | N/A | N/A | 11.50x | -46.00x | 0.52x | 2.93x | N/A | $24.19M | 25.33% | $48.47M | 0.47 | $117.98M | 4.72 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have a premium account? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.